NMR-based screening in drug discovery

Quarterly Reviews of Biophysics

Volumn 32, Issue 3, 1999, Pages 211-240

  Hajduk, Philip J ^a   Meadows, Robert P ^a   Fesik, Stephen W ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCOMYCIN; FK 506 BINDING PROTEIN; IMIDAZOLIDINE DERIVATIVE; LEAD; LIGAND; METHYLTRANSFERASE; METHYLTRANSFERASE INHIBITOR; PHOSPHOTYROSINE; PROTEIN; PROTEINASE INHIBITOR; SOLVENT; STROMELYSIN; VIRUS PROTEIN;

BINDING AFFINITY; COMPETITIVE INHIBITION; DIFFUSION; DRUG DESIGN; DRUG INHIBITION; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG TARGETING; ENZYME ASSAY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN TARGETING; PROTON NUCLEAR MAGNETIC RESONANCE; RELAXATION TIME; REVIEW; WART VIRUS;

BIOPHYSICS; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MATRIX METALLOPROTEINASE 3; METHYLTRANSFERASES; MODELS, MOLECULAR; PAPILLOMAVIRIDAE; SRC HOMOLOGY DOMAINS; TACROLIMUS BINDING PROTEINS; VIRAL PROTEINS;

HUMAN PAPILLOMAVIRUS TYPES;

EID: 0033341062     PISSN: 00335835     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033583500003528     Document Type: Review

References (75)

1. ALLEN, K. N., BELLAMACINA, C. R., DING, X., JEFFREY, C. J., MATTOS, C., PETSKO, G. A. & RINGE, D. (1996). An experimental approach to mapping the binding surfaces of crystalline proteins. J. Phys. Chem. 100, 2605-2611.
2. ALTIERE, A. S., HINTON, D. P. & BYRD, R. A. (1995). Association of biomolecular systems via pulsed field gradient NMR self-diffusion measurements. J. Am. Chem. Soc. 117, 7566-7567.
3. BECKETT, R. P., DAVIDSON, A. H., DRUMMOND, A. H., HUXLEY, P. & WHITTAKER, M. (1996). Recent advances in matrix metalloproteinase inhibitor research. Drug. Disc. Today 1, 16-26.
4. BEMIS, G. W. & MURCKO, M. A. (1996). The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 39, 2887-2893.
5. BLACK, R. D., EARLY, T. A., ROEMER, P. B., MUELLER, O. M., MODRO-CAMPERO, A., TURNER, L. G. & JOHNSON, G. A. (1993). A high-temperature super-conducting receiver for nuclear magnetic resonance spectroscopy. Science 259, 793.
6. BLEICHER, K., LIN, M., SHAPIRO, M. J. & WAREING, J. R. (1998). Diffusion-edited NMR: screening compound mixtures by affinity NMR to detect binding ligands to vancomycin. J. Org. Chem. 63, 8486-8490.
7. BOHM, H. J. (1995). Site-directed structure generation by fragment-joining. Persp. Drug Disc. Design 3, 21-33.
8. BOLS, M., BINDERUP, L., HANSEN, J. & RASMUSSEN, P. (1992). Inhibition of collagenase by aranciamycin and aranciamycin derivatives. J. Med. Chem. 35, 2768-2771.
9. BRUGGE, J. S. (1993). New intracellular targets for therapeutic drug design. Science 260, 918-919.
10. BURKE, T. R., JR., SMYTH, M. S., OTAKA, A., NOMIZU, M., ROLLER, P. P., WOLF, G., CASE, R. & SHOELSON, S. E. (1994). Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors. Biochemistry 33, 6490-6494.
11. CHEN, A. & SHAPIRO, M. J. (1998). NOE pumping: a novel NMR technique for identification of compounds with binding affinity to macromolecules. J. Am. Chem. Soc. 120, 10258-10259.
12. 13C-NMR. Chem. Pharm. Bull. 46, 718-720.
13. CLANCY, J., SCHMEIDER, B. J., PETITPAS, J. W., MANOUSOS, M., WILLIAMS, J. A., FAIELLA, J. A., GIRARD, A. E. & MCGUIRK, P. R. (1995). Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase. J. Antibiotics 48, 1273-1279.
14. COWSERT, L. M., FOX, M. C., ZON, G. & MIRABELLI, C. K. (1993). In vitro evaluation of phosphorothioate oligonucleotides targeted to the E2-messanger-RNA of papillomavirus - potential treatment for genital warts. Antimicrob. Agents Chemother. 37, 171-177.
15. DALVIT, C., FLOERSHEIM, P., ZURINI, M. & WIDMER, A. (1999). Use of organic solvents and small molecules for locating binding sites on proteins in solution. J. Biomol. NMR 14, 23-32.
16. DENOYA, C. & DUBNAU, D. (1989). Mono- and dimethylating activities and kinetic studies of the ErmC 23S rRNA methyltransferase. J. Biol. Chem. 264, 2615-2624.
17. DOCHERTY, A. J. P., O'CONNELL, J., CRABBE, T., ANGAL, S. & MURPHY, G. (1992). The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends in Biotech. 10, 200-207.
18. EADY, E. A., ROSS, J. I. & COVE, J. H. (1990). Multiple mechanisms of erythromycin resistance. Antimier. Chemo. 26, 461-471.
19. ECK, M. J., ATWELL, S. K., SHOELSON, S. E. & HARRISON, S. C. (1994). Structure of the regulatory domains of the Src-family tyrosine kinasc Lck. Nature 368, 764-769.
20. ECK, M. J., SHOELSON, S. E. & HARRISON, S. C. (1993). Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck. Nature 362, 87-91.
21. EWING, T. J. A. & KUNTZ, I. D. (1997). Critical evaluation of search algorithms for automated molecular docking and database screening. J. Comp. Chem. 18, 1175-1189.
22. FAUCHERE, J. L., BOUTIN, J. A., HENLIN, J. M., KUCHARCZYK, N. & ORTUNA, J. C. (1998). Combinatorial chemistry for the generation of molecular diversity and the discovery of bioactive leads. Chemom. Intell. Lab. Sys. 43, 43-68.
23. FECIK, R. A., FRANK, K. E., GENTRY, E. J., MENON, S. R., MITSCHER, L. A. & TELIKEPALLI, H. (1998). The search for orally active medications through combinatorial chemistry. Research Rev. 18, 149-185.
24. FEJZO, J., LEPRE, C. A., PENG, J. W., BEMIS, G. W., AJAY, X., MURCKO, M. A. & MOORE, J. M. (1999). The SHAPES strategy: an NMR-based approach for lead generation in drug discovery. Chemistry & Biology 6, 755-769.
25. FERNANDES, P. B. (1998). Technological advances in high-throughput screening. Curr. Op. Chem. Biol. 2, 597-603.
26. GARDNER, K. H., ROSEN, M. K. & KAY, L. E. (1997). Global folds of highly deuterated, methyl-protonated proteins by multidimensional NMR. Biochemistry 36, 1389-1401.
27. GONNELLA, N., LIN, M., SHAPITO, M. J., WAREING, J. R. & ZHANG, X. (1998). Isotope-filtered affinity NMR. J. Magn. Reson. 131, 336-338.
28. GOODFORD, P. J. (1985). A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 28, 849-857.
29. GORLACH, M., WITTEKIND, M., BECKMAN, R. A., MUELLER, L. & DREYFUSS, G. (1992). Interaction of the RNA-binding domain of the hnRNP C proteins with RNA. EMBO J. 11, 3289-3295.
30. HAJDUK, P. J., MEADOWS, R. P. & FESIK, S. W. (1997a). Discovering high-affinity ligands for proteins. Science 278, 497-499.
31. HAJDUK, P. J., OLEJNICZAK, E. T. & FESIK, S. W. (1997b). One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules. J. Am. Chem. Soc. 119, 12257-12261.
32. HAJDUK, P. J., SHEPPARD, G., NETTESHEIM, D. G., OLEJNICZAK, E. T., SHUKER, S. B., MEADOWS, R. P., STEINMAN, D. H., CARRERA, G. M., MARCOTTE, P. A., SEVERIN, J., WALTER, K., SMITH, H., GUBBINS, E., SIMMER, R., HOLZMAN, T. F., MORGAN, D. W., DAVIDSEN, S. K. & FESIK, S. W. (1997c). Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR. J. Am. Chem. Soc. 119, 5818-5827.
33. HAJDUK, P. J., DINGES, J., MIKNIS, G. F., MERLOCK, M., MIDDLETON, T., KEMPF, D. J., EGAN, D. A., WALTER, K. A., ROBINS, T. S., SHUKER, S. B., HOLZMAN, T. F. & FESIK, S. W. (1997d). NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein. J. Med. Chem. 40, 3144-3150.
34. HAJDUK, P. J., GERFIN, T., BOEHLEN, J.-M., HÄBERLI, M., MAREK, D. & FESIK, S. W. (1999a). High-throughput nuclear magnetic resonance based screening. J. Med. Chem. 42, 2315-2317.
35. HAJDUK, P. J., DINGES, J., SCHKERYANTZ, J. M., JANOWICK, D., KAMINSKI, M., TUFANO, M., AUGERI, D. J., PETROS, A., NIENABER. V., ZHONG, P., HAMMOND, R., COEN, M., BEUTEL, B., KATZ, L. & FESIK, S. W. (1999b). Novel inhibitors of Erm methyltransferases from NMR and parallel synthesis. J. Med. Chem. 42, 3859-3859.
36. HAJDUK, P. J., ZHOU, M.-M. & FESIK, S. W. (1999c). NMR-based discovery of phosphotyrosine mimetics that bind to the Lck SH2 domain. Bioorg. Med. Chem. Lett. 9, 2403-2406.
37. HARRIS, G. H., HOOGSTEEN, K., SILVERMAN, K. C., RAGHOOBAR, S. L. & BILLS, G. F. (1993). Isolation and structure determination of pycnidione. A novel bistropolone stromelysin inhibitor from a Phoma sp. Tetrahedron 49, 2139-2144.
38. HOWE, L. R. & WEISS, A. (1995). Multiple kinases mediate T-cell receptor signaling. TIBS 20, 59-64.
39. IKURA, M. & BAX, A. (1992). Isotope-filtered 2D NMR of a protein-peptide complex: study of a skeletal myosin light chain kinase fragment bound to calmodulin. J. Am. Chem. Soc. 114, 2433.
40. JENCKS, W. P. (1981). On the attribution and additivity of binding energies. Proc. Natl. Acad. Sci. USA 78, 4046-4050.
41. KALLEN, J., SPITZFADEN, C., ZURINI, M. G. M., WIDER, G., WIDMER, H., WÜTHRICH, K. & WALKINSHAW, M. D. (1991). Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy. Nature 353, 276-279.
42. KAY, L. E., KEIFER, P. & SAARINEN, T. (1992). Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J. Am. Chem. Soc. 114, 10663-10665.
43. KLEIN, J., MEINECKE, R., MAYER, M. & MEYER, B. (1999). Detecting binding affinity to immobilized receptor proteins in compound libraries by HR-MAS STD NMR. J. Am. Chem. Soc. 121, 5336-5337.
44. LEHMANN, M. S. & STANSFIELD, R. F. D. (1989). Binding of dimethyl sulfoxide to lysozyme in crystals, studied with neutron diffraction. Biochemistry 28, 7028-7033.
45. LIEPINSH, E. & OTTING, G. (1997). Organic solvents identify specific ligand binding sites on protein surfaces. Nature Biotech. 15, 264-268.
46. LIN, M., SHAPIRO, M. J. & WAREING, J. R. (1997a). Diffusion-edited NMR - affinity NMR for direct observation of molecular interactions. J. Am. Chem. Soc. 119, 5249-5250.
47. LIN, M., SHAPIRO, M. J. & WAREING, J. R. (1997b). Screening mixtures by affinity NMR. J. Org. Chem. 62, 8930-8931.
48. LIOTTA, L. A., RAO, C. N. & WEWER, U. M. (1986). Biochemical interactions of tumor cells with the basement membrane. Ann. Rev. Biochem. 55, 1037-1057.
49. MAREK, D., HAEBERLI, M., TRIEBE, R., BASELGIA, L., GERGIN, T., SCHETT, O. & LAUKIEN, F. (1997). Ultra sensitive high-resolution NMR probes. ENC97 Poster P122.
50. MAREK, D., WITHERS, R., NAST, R., HAEBERLI, M., BASEGLIA, L., GERFIN, T., CALDERON, P. & MEHTRA, S. (1998). Cryogenic high-resolution NMR probes. ENC97 Poster 227.
51. MARTIN, Y. C. (1997). Challenges and prospects for computational aids to molecular diversity. Persp. Drug Disc. Design 7/8, 159-172.
52. MAYER, M. & MEYER, B. (1999). Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem. Int. Ed. 38, 1784-1788.
53. MEYER, B., WEIMAR, T. & PETERS, T. (1997). Screening mixtures for biological activity by NMR. Eur. J. Biochem. 246, 705-709.
54. MIRANKER, A. & KARPLUS, M. (1995). An automated method for dynamic ligand design. Proteins 23, 472-490.
55. MOORE, J. M. (1999). NMR screening in drug discovery. Curr. Opin. Biotech. 10, 54-58.
56. MOORE, J. W. (1972). Physical Chemistry, 4th edn. Prentice-Hall, Inc.: Englewood Cliffs.
57. OLDENBURG, K. R., ZHANG, J. H., CHEN, T. M., MAFFIA, A., BLOM, K. F., COMBS, A. P. & CHUNG, T. D. Y. (1998). Assay miniaturizations for ultra-high throughput screening of combinatorial and discrete compound libraries - a 9600-well (0·2 microliter) assay system. J. Biomol. Screening 3, 55-62.
58. OLEJNICZAK, E. T., HAJDUK, P. J., MARCOTTE, P. A., NETTESHEIM, D. G., MEADOWS, R. P., EDALJI, R., HOLZMAN, T. F. & FESIX, S. W. (1997). Stromelysin inhibitors designed from weakly bound fragments: effects of linking and cooperativity. J. Am. Chem. Soc. 119, 5828-5832.
59. PEPINSKY, R. B., ANDROPHY, E. J., CORINA, K., BROWN, R. & BARSOUM, J. (1994). Specific inhibition of a human papillomavirus E2 trans-activator by intracellular delivery of its receptor. DNA Cell Biol. 13, 1011-1019.
60. 2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl. Acad. Sci. USA 94, 12336-12371.
61. PIKE, A. C. & ACHARYA, K. R. (1994). A structural basis for the interaction of urea with lysozyme. Protein Sci. 3, 706-710.
62. RIEK, R., WIDER, G., PERVUSHIN, K. & WÜTHRICH, K. (1999). Polarization transfer by cross-correlated relaxation in solution NMR with very large molecules. Proc. Natl. Acad. Sci. USA 96, 4918-4923.
63. SHUKER, S. B., HAJDUK, P. J., MEADOWS, R. P. & FESIK, S. W. (1996). Discovering high-affinity ligands for proteins: SAR by NMR. Science 274, 1531-1534.
64. SILVERMAN, L., CAMPBELL, R. & BROACH, J. R. (1998). New assay technologies for high-throughput screening. Curr. Op. Chem. Biol. 2, 397-403.
65. STAMS, T., SPURLINO, J. C., SMITH, D. L., WAHL, R. C., HO, T. F., QORONFLEH, M. W., BANKS, T. M. & RUBIN, B. (1994). Structure of human neutrophil collagenase reveals large S1′ specificity pocket. Nature Struct. Biol. 1, 119-123.
66. STYLES, P., SOFFE, N. F., SCOTT, C. A., CRAGG, D. A., ROW, F., WHITE, D. J. & WHITE, P. C. J. (1984). A high-resolution NMR probe in which the coil and preamplifier are cooled with liquid helium. J. Magn. Reson. 60, 397-404.
67. SUOMALAINEN, K., SORSA, T., GOLUB, L. M., RAMAMURTHY, N., LEE, H. M., UTTTO, V. J., SAARI, H. & KONTTINEN, Y. T. (1992). Specificity of the anticollagenase action of tetracyclins: relevance to their anti-inflammatory potential. Antimicrob. Agents Chemother. 36, 227-229.
68. SWANSON, R. V., LOWRY, D. F., MATSUMURA, P., MCEVOY, M. M., SIMON, M. I. & DAHLQUIST, F. W. (1995). Localized perturbations in CheY structure monitored by NMR identify a CheA binding interface. Nature Struct. Biol. 2, 906-910.
69. TONG, L., WARREN, T. C., LUKAS, S., SCHEMBRI-KING, J., BETAGERI, R., PROUDFOOT, J. R. & JAKES, S. (1998). Carboxymethyl-phenylalanine as a replacement for phosphotyrosine in SH2 domain binding. J. Biol. Chem. 273, 20238-20242.
70. VAN DUYNE, G. D., STANDAERT, R. F., SCHREIBER, S. L. & CLARDY, J. (1991). Atomic structure of the rapamycin human immunophilin FKBP-12 complex. J. Am. Chem. Soc. 113, 7433-7434.
71. WALAKOVITS, L. A., MOORE, V. L., BHARDWAJ, N., GALLICK, G. S. & LARK, M. W. (1992). Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum. 35, 35-42.
72. WILHELM, S. M., SHAO, Z.-H., HOUSLEY, T. J., SEPERACK, P. K., BAUMANN, A. P., GUNJA-SMITH, Z. & WOESSNER, J. F., JR. (1993). Matrix metalloproteinase-3 (stromelysin-1). Identification as the cartilage acid metalloproteinase and effect of pH on catalytic properties and calcium affinity. J. Biol. Chem. 268, 21906-21913.
73. YE, B., AKAMATSU, M., SHOELSON, S. E., WOLF, G., GIORGETTI-PERALDI, S., YAN, X., ROLLER, P. P. & BURKE, T. R., JR. (1995). L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2. Domain inhibitory peptides. J. Med. Chem. 38, 4270-4275.
74. ZHENG, J., CAHILL, S. M., LEMMON, M. A., FUSHMAN, D., SCHLESSINGER, J. & COWBURN, D. (1996). Identification of the binding site for acidic phospholipids on the PH domain of dynamin: implications for stimulation of GTPase activity. J. Mol. Biol. 255, 14-21.
75. ZHOU, M.-M., HARLAN, J. E., WADE, W. S., CROSBY, S., RAVICHANDRAN, K. S., BURAKOFF, S. J. & FESIK, S. W. (1995). Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal and NH2-terminal phosphotyrosine binding domain of She. J. Biol. Chem. 270, 31119-31123.